EMEA-001056-PIP02-12-M01 - paediatric investigation plan
velmanase alfa
PIPHuman
Chiesi Farmaceutici S.p.A.
Tel. +39 0521 2791
E-mail: info@chiesi.com
P/0407/2020: EMA decision of 23 October 2020 on the acceptance of a modification of an agreed paediatric investigation plan for velmanase alfa (Lamzede), (EMEA-001056-PIP02-12-M01)